Suppr超能文献

原发肛门癌调强放化疗患者的生活质量。

Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer.

机构信息

Department of Radiation Oncology, Klinikum rechts der Isar, TU München, Ismaninger Str. 22, 81675, Munich, Germany.

Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.

出版信息

Sci Rep. 2022 Mar 15;12(1):4416. doi: 10.1038/s41598-022-08525-1.

Abstract

Anal cancer and the related treatment are generally known to affect patients' quality of life. The aim of this study was to assess self-reported quality of life (QoL) of anal cancer patients after combined radiation and chemotherapy, and to identify patient-, disease-, and therapy-related factors associated with QoL. A total of 94 patients treated with definitive chemoradiation for anal cancer at our institution in the period from 2004 to 2018 were identified from our database. QoL was assessed in the remaining 52 patients using the EORTC QLQ-C30 questionnaire (cancer-specific QoL) and the newly developed anal cancer module QLQ-ANL27 (site-specific QoL). Differences in QoL between anal cancer patients and a German age and sex adjusted reference population were examined. The median follow-up was 71 months (range, 7-176). In the cancer-specific QoL module, the anal cancer cohort presented with significantly lower scores in role (- 12.2 points), emotional (- 6.6 points), and social functioning (- 6.8 points), but higher scores in diarrhea (+ 36.3 points) and constipation (+ 13.3 points) than the German reference population. There were no significant differences in disease- or therapy-related factors, but age greater than 70 years and a follow-up time greater than 71 months had a negative impact on global QoL. As for the site-specific QoL, patients with a tumor relapse showed significantly higher symptom scores than patients with a complete clinical remission in all scales except of micturition frequency. Compared to 3D conformal radiotherapy, IMRT treatment seemed to improve non-stoma bowel function (+ 23.3 points), female sexual functioning (+ 24.2 points), and came along with less scores in the symptom scales pain (- 35.9 points), toilet proximity (- 28.6 points), and cleanliness (- 26.2 points). Most of the functional scores of anal cancer patients were lower compared to the general German population, but did not seem to affect the general QoL. Fatigue, physical, and role functioning had the strongest impact on global QoL causing psychological symptoms as important as physical.

摘要

肛门癌及其相关治疗通常被认为会影响患者的生活质量。本研究旨在评估接受放化疗的肛门癌患者的生活质量(QoL)自评,并确定与 QoL 相关的患者、疾病和治疗相关因素。我们从数据库中确定了 2004 年至 2018 年期间在我院接受根治性放化疗的 94 例肛门癌患者。使用 EORTC QLQ-C30 问卷(癌症特异性 QoL)和新开发的肛门癌模块 QLQ-ANL27(局部特异性 QoL)评估了 52 例剩余患者的 QoL。比较了肛门癌患者与德国年龄和性别调整参考人群之间的 QoL 差异。中位随访时间为 71 个月(范围 7-176)。在癌症特异性 QoL 模块中,肛门癌组在角色功能(-12.2 分)、情绪功能(-6.6 分)和社会功能(-6.8 分)方面的评分明显较低,但在腹泻(+36.3 分)和便秘(+13.3 分)方面的评分较高。在疾病或治疗相关因素方面无显著差异,但年龄大于 70 岁和随访时间大于 71 个月对总体 QoL 有负面影响。在局部特异性 QoL 方面,与完全临床缓解的患者相比,肿瘤复发的患者在所有量表中除排尿频率外,症状评分均较高。与 3D 适形放疗相比,调强放疗似乎可以改善非造口肠功能(+23.3 分)、女性性功能(+24.2 分),并在症状量表中疼痛(-35.9 分)、厕所接近度(-28.6 分)和清洁度(-26.2 分)方面的评分较低。与一般德国人群相比,肛门癌患者的大多数功能评分较低,但似乎并未影响总体 QoL。疲劳、躯体和角色功能对总体 QoL 的影响最大,导致心理症状与躯体症状同样重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/8924204/ac01d610bf5d/41598_2022_8525_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验